Replies to post #2812 on Idera Pharmaceuticals Inc (IDRA)

[kld2]

I don't expect much from IDRA abstract. A poster only. Might be some nuggets of good news, but a price mover? Maybe.

I do think that if price moves up it will be supported, there won't be the patent IDRA pull-back: there are too many 2017 catalysts, and it's oversold. In at 1.61.

[kld2]

I imagine we should get a pr tomorrow morning, because, per Bob Doody, IDRA will definitely be presenting data.